Levosimendan is a positive inotrope with vasodilating properties (inodilator) indicated for
decompensated heart failure (HF) patients with low cardiac output. Accumulated evidence …

Purpose There is controversy about the use of inotropes in the treatment of severe sepsis
and septic shock. The objective of this study was to evaluate if levosimendan, as compared …

Abstract Resolvin D1 (RvD1), an endogenous lipid molecule derived from docosahexaenoic
acid (DHA), has been described to promote inflammatory resolution. The present study …

Introduction The purpose of the present study was to investigate microcirculatory blood flow
in patients with septic shock treated with levosimendan as compared to an active …

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A
Randomized Controlled Trial - PMC Back to Top Skip to main content NIH NLM Logo Access …

Objectives: The calcium sensitizer levosimendan is used in treatment of decompensated
heart failure and may also exhibit anti-inflammatory properties. We examined whether …

Levosimendan and milrinone may be used in place of dobutamine to increase cardiac
output in septic patients with a low cardiac output due to impaired cardiac function. The …

Current hemodynamic monitoring of critically ill patients is mainly focused on monitoring of
pressure-derived hemodynamic variables related to systemic circulation. Increasingly …

Asiaticoside (AS), a major triterpenoid saponin component isolated from Centella asiatica,
has been described to exhibit antioxidant and anti-inflammatory activities. The present study …

To investigate the effects of dobutamine hydrochloride on early postoperative cognitive
dysfunction (POCD) and plasma tumor necrosis factor (TNF)-α concentration in patients …